Roche provided early Phase 1 clinical trial data last week that showed its pill provided 6.1% weightloss over four weeks ... including Pfizer (PFE), Novo, and Lilly. Pfizer recently ...
Pfizer recently revealed Phase 2 clinical ... Patients showed 13.1% weightloss after 12 weeks on the pill, compared to 6% after 12 weeks in Wegovy's early trial. Terns showed its early-stage ...
Results that may be inaccessible to you are currently showing.